HIV-related malignancies pre- and post-highly active antiretroviral therapy: Experiences in an inner city tertiary referral centre

International Journal of STD and AIDS

Volumn 21, Issue 5, 2010, Pages 332-336

  Kiely, B ^a   O'Flaherty, J ^a   Surah, S ^a   Kieran, J ^a   O'Donnell, D ^a   Bergin, C ^a   Mulcahy, F ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

AIDS; HAART; HIV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANUS CARCINOMA; ARTICLE; B CELL LYMPHOMA; BRAIN LYMPHOMA; BURKITT LYMPHOMA; CANCER INCIDENCE; CANCER REGRESSION; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HEAD AND NECK CANCER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLASTIC LYMPHOMA; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD REVIEW; NONHODGKIN LYMPHOMA; PLASMABLASTIC LYMPHOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TERTIARY HEALTH CARE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; IRELAND; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; URBAN POPULATION;

EID: 77952809851     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009486     Document Type: Article

References (14)

1. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008;123:187-194 (Pubitemid 351705208)
2. Anitnori A, Cingolani A, Alba L, et al. Better response to chemotherapy and prolonged survival in AIDS related lymphomas responding to highly active antiretroviral therapy. AIDS 2001;15:1483-1491 (Pubitemid 32744595)
3. Bower M, Collins S, Cottrill C, et al., AIDS Malignancy Subcommittee. British HIV Association Guidelines for HIV associated malignancies 2008. HIV Med 2008;9:336-388
4. O'Reilly M, Bergin C, Mulcahy F. AIDS-related malignancies in Ireland 1987-1994. J Eur Acad Dermatol Venerol 1997;8:116-120
5. Serraino D, Angeletti C, Carrieri MP, et al. Kaposi's sarcoma in transplant and HIV infected patients: an epidemiological study in Italy and France. Transplantation 2005;80: 1699-1704
6. Mocroft A, Katlama C, Johnson AM, et al. AIDS across Europe 1994-1998: the EuroSIDA study. Lancet 2000;356:291-296
7. Diamond C, Taylor TH, Aboumrad T, et al. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer 2006;106:128-135 (Pubitemid 43032557)
8. Matthews GV, Bower M, Mandalia S, et al. Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood 2000;96;2730-2734
9. Stebbing J, Gazzard B, Mandalia S, et al. Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma. J Clin Oncol 2004;22:2177-2183 (Pubitemid 41095153)
10. Clifford GM, Polesel J, Rickenbach M, et al., Swiss HIV Cohort. Cancer risk in the Swiss Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005;97:425-432
11. Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249-256 (Pubitemid 38942814)
12. Engels EA, Pfeiffer RM, Goedert JJ, et al., for the HIV/AIDS Cancer Match Study. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006;20:1645-1654
13. Hoffmann C, Chow KU, Wolfe E, et al. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Br J Haematol 2004;125:455-462 (Pubitemid 38916190)
14. Burgi A, Brodine S, Wegner S, et al. Incidence and risk factors for the occurrence of non AIDS defining cancers among human immunodeficiency virus infected individuals. Cancer 2005;104:1505-1511 (Pubitemid 41356166)